Zobrazeno 1 - 10 of 24 pro vyhledávání: '"Tomomi Takei"'
2
Explainable AI for Estimating Pathogenicity of Genetic Variants Using Large-Scale Knowledge Graphs
Autor: Shuya Abe, Shinichiro Tago, Kazuaki Yokoyama, Miho Ogawa, Tomomi Takei, Seiya Imoto, Masaru Fuji
Publikováno v: Cancers
Volume 15
Issue 4
Pages: 1118
Background: To treat diseases caused by genetic variants, it is necessary to identify disease-causing variants in patients. However, since there are a large number of disease-causing variants, the application of AI is required. We propose AI to solve
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ada0537c380df7eab7bf78dd5c5c6dd
Zobrazit plný text záznamu
3
Prognostic impact of circulating tumor DNA status post–allogeneic hematopoietic stem cell transplantation in AML and MDS
Autor: Yuka Wada, Arinobu Tojo, Asako Kobayashi, Satoru Miyano, Eigo Shimizu, Takaaki Konuma, Nozomi Yusa, Mika Ito, Tomomi Takei, Kanya Kondoh, Seiko Kato, Miho Ogawa, Masamichi Isobe, Kazuaki Yokoyama, Rika Kasajima, Satoshi Takahashi, Sousuke Nakamura, Tokiko Nagamura-Inoue, Seiya Imoto, Rui Yamaguchi
Publikováno v: Blood. 133:2682-2695
This study was performed to assess the utility of tumor-derived fragmentary DNA, or circulating tumor DNA (ctDNA), for identifying high-risk patients for relapse of acute myeloid leukemia and myelodysplastic syndrome (AML/MDS) after undergoing myeloa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e56bdefc91b7e637c9ca4fa8b3080f
https://doi.org/10.1182/blood-2018-10-880690
Zobrazit plný text záznamu
5
Circulating tumor DNA dynamically predicts response and/or relapse in patients with hematological malignancies
Autor: Satoru Miyano, Miho Ogawa, Mika Ito, Rika Kasajima, Rui Yamaguchi, Asako Kobayashi, Eigo Shimizu, Kazuaki Yokoyama, Yuka Wada, Sousuke Nakamura, Seiya Imoto, Tomomi Takei, Nozomi Yusa, Tokiko Nagamura-Inoue, Arinobu Tojo
Publikováno v: International Journal of Hematology. 108:402-410
A growing body of evidence suggests that tumor-derived fragmentary DNA, known as circulating tumor DNA (ctDNA), has the potential to serve as a non-invasive biomarker for disease monitoring. However, in the setting of hematological malignancy, few pu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21805b2e29f69e7b903f554590b860e6
https://doi.org/10.1007/s12185-018-2487-2
Zobrazit plný text záznamu
6
Nested Polymerase Chain Reaction with Specific Primers for Mucorales in the Serum of Patients with Hematological Malignancies
Autor: Hiroshi Yotsuyanagi, Mitsuhito Hirano, Toyotaka Kawamata, Kazuaki Yokoyama, Kaoru Uchimaru, Yoichi Imai, Yasunori Ota, Reina Takeda, Arinobu Tojo, Tomomi Takei, Tomohiko Koibuchi
Publikováno v: Japanese journal of infectious diseases. 72(3)
Mucormycosis is an opportunistic infection occurring in immunocompromised hosts with hematological malignancies. Mortality due to mucormycosis in patients with hematological malignancies is high. However, the clinical symptoms of mucormycosis are poo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75d0b4c4ed11a32ec154a0e1845a5a1d
https://pubmed.ncbi.nlm.nih.gov/30584197
Zobrazit plný text záznamu
7
Cell-lineage level–targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes
Autor: Eigo Shimizu, Sousuke Nakamura, Satoru Miyano, Mika Ito, Miho Ogawa, Nozomi Yokoyama, Tomomi Takei, Arinobu Tojo, Seiya Imoto, Kazuaki Yokoyama, Rika Kasajima, Rui Yamaguchi, Asako Kobayashi
Acute myeloid leukemia (AML) is a clonal myeloid neoplasm that typically arises de novo; however, some cases evolve from a preleukemic state, such as myelodysplastic syndrome (MDS). Such secondary AMLs and those with typical MDS-related clinical feat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58a4327ff26d7b9dd17230fda6f32311
https://europepmc.org/articles/PMC6177645/
Zobrazit plný text záznamu
9
[IgE-κ type multiple myeloma achieving complete response with novel agents]
Autor: Tomomi, Takei, Tadao, Ishida, Masahiro, Ikeda, Sumito, Shingaki, Kanji, Miyazaki, Yumiko, Yoshiki, Yu, Abe, Kiyoshi, Okazuka, Seiko, Iki, Nobuhiro, Tsukada, Kenshi, Suzuki
Publikováno v: [Rinsho ketsueki] The Japanese journal of clinical hematology. 58(11)
IgE multiple myeloma (MM) is a rare subtype of MM characterized by an aggressive and poor prognosis. Although novel agents have improved the prognosis of MM, there are few case reports of IgE MM treated with these agents. A 53-year-old male patient p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a409b12ed7e34cd4a77e03d60e5d4eb6
https://pubmed.ncbi.nlm.nih.gov/29212974
Zobrazit plný text záznamu
10
Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantation
Autor: Maki Oiwa-Monna, Hiroto Ishii, Shinji Mochizuki, Satoshi Takahashi, Tomomi Takei, Yasuhiro Ebihara, Takaaki Konuma, Jun Ooi, Seiko Kato, Arinobu Tojo
Publikováno v: Leukemia & Lymphoma. 57:103-109
The efficacy of second allogeneic stem cell transplantation (SCT2) using cord blood (CB) for patients with relapsed hematological malignancies after initial allogeneic stem cell transplantation (SCT1) is unknown. We analyzed the results of SCT2 using
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::986b49e807e6f0f9dd27ecf8f3fced7a
https://doi.org/10.3109/10428194.2015.1045900
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje